Cover for Advances in Pharmacological Research and Practice

Advances in Pharmacological Research and Practice

Proceedings of the 4th Congress of the Hungarian Pharmacological Society, Budapest, 1985

Book1986

Edited by:

L. SZEKERES, J.GY. PAPP, ... G. RABLOCZKY

Advances in Pharmacological Research and Practice

Proceedings of the 4th Congress of the Hungarian Pharmacological Society, Budapest, 1985

Book1986

 

Cover for Advances in Pharmacological Research and Practice

Edited by:

L. SZEKERES, J.GY. PAPP, ... G. RABLOCZKY

Browse this book

Book description

Advances in Pharmacological Research and Practice, Volume 1: Pharmacological Protection of the Myocardium presents the proceedings of the 4th Congress of the Hungarian Pharmacologi ... read full description

Browse content

Table of contents

Actions for selected chapters

Select all / Deselect all

  1. Full text access
  2. Book chapterNo access

    INTRODUCTION

    L. SZEKERES

    Pages 3-4

  3. Book chapterNo access

    THE CYCLIC AMP—PROTEIN KINASE SYSTEM IN ACUTE MYOCARDIAL ISCHAEMIA

    A. WOLLENBERGER, S. BARTEL and E.-G. KRAUSE

    Pages 5-12

  4. Book chapterNo access

    CELLULAR ELECTROPHYSIOLOGICAL DISORDERS IN ACUTE MYOCARDIAL ISCHAEMIA AND THEIR MODIFICATION BY DRUGS

    J.GY. PAPP and L. SZEKERES

    Pages 13-24

  5. Book chapterNo access

    ANTIARRHYTHMIC EFFECTS OF POSSIBLE ANTI-ISCHEMIC DRUGS

    K. HASHIMOTO, H. MITSUHASHI, ... K. AKIYAMA

    Pages 25-31

  6. Book chapterNo access

    PROTECTION OF THE ISCHAEMIC HEART. PREVENTION OF PRIMARY VENTRICULAR FIBRILLATION

    L. SZEKERES, M. KOLTAI, ... T. FAZEKAS

    Pages 33-43

  7. Book chapterNo access

    REFLECTIONS ON THE MODE OF ACTION OF BETA-ADRENOCEPTOR ANTAGONISTS IN PROLONGING LIFE AFTER ACUTE MYOCARDIAL INFARCTION

    J.D. FITZGERALD

    Pages 45-51

  8. Book chapterAbstract only

    CARDIOPROTECTIVE AND CEREBROPROTECTIVE EFFECT OF LIPOCORTIN-LIKE SUBSTANCES

    M. KOLTAI, I. LEPRAN, ... L. SZEKERES

    Pages 53-59

  9. Book chapterNo access

    ANTIISCHAEMIC ACTIONS OF CALCIUM ANTAGONISTS

    T. GODFRAIND

    Pages 61-66

  10. Book chapterNo access

    CARDIO-PROTECTIVE AND -NONPROTECTIVE EFFECTS OF DRUGS DURING ANOXIA AND REOXYGENATION

    M. SIESS

    Pages 67-72

  11. Book chapterNo access

    CARDIAC GLYCOSIDES AND MYOCARDIAL ISCHAEMIA

    K. GREEFF

    Pages 73-79

  12. Book chapterNo access

    PHARMACOLOGICAL CONTROL OF THROMBOTIC PROCESSES FOR PREVENTION OF MYOCARDIAL ISCHAEMIA

    F. MARKWARDT

    Pages 81-87

  13. Book chapterNo access

    THE PHARMACOLOGICAL PROTECTION OF THE ISCHAEMIC MYOCARDIUM. PROBLEMS AND POSSIBILITIES

    J.R. PARRATT

    Pages 89-98

  14. Book chapterNo access

    ETHACIZINE: ANTIARRHYTHMIC AND ANTIISCHAEMIC PROPERTIES

    N.V. KAVERINA

    Pages 99-102

  15. Book chapterNo access

    EFFECTS OF DILTIAZEM AND VERAPAMIL IN A NEW CANINE MODEL OF MYOCARDIAL INFARCTION

    AGNES VÉGH, ÉVA UDVARY and L. SZEKERES

    Pages 103-107

  16. Book chapterNo access

    POSSIBLE DIFFERENCES AMONG THE DRUG-INDUCED RESPONSES OF THE DESCENDING AND CIRCUMFLEX CORONARY ARTERIES IN THE ANAESTHETIZED DOG

    IREN KRASSÓI, ÉVA UDVARY and L. SZEKERES

    Pages 109-112

  17. Book chapterNo access

    BETA-ADRENOLYTIC WITHDRAWAL REBOUND PHENOMENON: AN INTRODUCTION

    F. INCZINGER and P. Ŝar;VEC

    Pages 113-116

  18. Book chapterNo access

    A CONTRIBUTION TO THE MECHANISM OF BETA-ADRENOLYTIC WITHDRAWAL SYNDROME

    E. BÉDEROVÁ, I. TUMOVÁ and P. Ŝar;VEC

    Pages 117-120

  19. Book chapterNo access

    ALTERATIONS IN THE EFFICACY OF BETA-ADRENOTROPIC DRUGS DUE TO CHANGES IN THE TONE OF THE AUTONOMIC NERVOUS SYSTEM

    J. SEGINKO, P. Ŝar;VEC, ... F. INCZINGER

    Pages 121-124

  20. Book chapterNo access

    ARTERIOVENOUS DIFFERENCE IN THE INHIBITION OF PLATELET AGGREGATION BY THE ANTIANGINAL DRUG: CH-102

    J. PATARICZA, P. BOR and L. SZEKERES

    Pages 125-128

  21. Book chapterNo access

    INHIBITION OF ADENYLATE CYCLASE BY Ca2+ IN THE ISCHAEMIC MYOCARDIUM. A CONCEPT OF PROTECTION BY Ca2+ CHANNEL AND β-BLOCKADE

    L. WILL-SHAHAB, I. KÜTTNER, ... S. BARTEL

    Pages 129-133

  22. Book chapterNo access

    PROTECTIVE EFFECT OF CALCIUM ANTAGONISTS ON ISCHAEMIC MYOCARDIAL METABOLISM DUE TO VASOPRESSIN INDUCED CORONARY SPASM

    I. TAKÁTS and L. SZEKERES

    Pages 135-138

  23. Book chapterNo access

    INHIBITION OF CAMP-PHOSPHODIESTERASE FROM HEART AND CORONARY ARTERIES BY A NEW TRAPIDIL DERIVATIVE

    E.-G. KRAUSE, H. TENOR, ... H.J. MEST

    Pages 139-142

  24. Book chapterNo access

    COMPARISON OF THREE CALCIUM ANTAGONISTS, VERAPAMIL, DILTIAZEM AND FENDILINE ON THE ENERGETIC STATE OF ISOLATED LANGENDORFF RAT HEART

    Á. TÓSAKI, I. TAKÁTS, ... L. SZEKERES

    Pages 143-146

  25. Book chapterNo access

    EFFECT OF IS, A WATER SOLUBLE DERIVATIVE OF INDOMETHACIN, ON THE OUTCOME OF THE VERY EARLY PHASE OF EXPERIMENTAL MYOCARDIAL INFARCTION IN CONSCIOUS RATS

    ILONA KAHÁNNÉ-LÁSZLÓ, I. LEPRÁN, ... L. SZEKERES

    Pages 147-150

  26. Book chapterNo access

    THE USE OF VOLTAGE CLAMP IN THE TESTING OF ANTIARRHYTHMIC DRUGS

    K. KELEMEN and RAISA MARKO

    Pages 151-157

  27. Book chapterNo access

    INTRACELLULAR ELECTROPHYSIOLOGICAL EFFECTS OF AMIODARONE AFTER ACUTE AND CHRONIC APPLICATION IN GUINEA PIG VENTRICULAR AND DOG PURKINJE FIBERS

    A. VARRÓ, Y. NAKAYA, ... B. SURAWICZ

    Pages 159-162

  28. Book chapterNo access

    ELECTRICAL AND MECHANICAL ACTIVITY OF THE MYOCARDIUM AS AFFECTED BY CH-101, AN ANTIARRHYTHMIC AGENT WITH PREFERENTIAL SUPRAVENTRICULAR ACTION

    O. HÁLA, J.Gy. PAPP and L. SZEKERES

    Pages 163-167

  29. Book chapterNo access

    INVOLVEMENT OF THE CENTRAL NICOTINIC RECEPTORS IN THE GENESIS OF THE CENTROGENIC CARDIAC ARRHYTHMIAS IN RATS

    B. CUPARENCU, D.N. SAFTA, ... A. VERESS

    Pages 169-172

  30. Book chapterNo access

    MORPHINE AND TIFLUADOM-INDUCED CENTROGENIC ARRHYTHMIAS IN ANAESTHETIZED RATS

    D.N. SAFTA, B. CUPARENCU and VIORICA ARUSTEI

    Pages 173-176

  31. Book chapterNo access

    STRUCTURE—ANTIARRHYTHMIC ACTIVITY RELATIONSHIP OF THE AMINO-ALCOHOL DERIVATIVES

    B. CEBO, J. KRUPINSKA, ... M. ECKSTEIN

    Pages 177-181

  32. Book chapterNo access

    LONG TERM-TREATMENT OF CARDIAC ARRHYTHMIAS WITH NADOLOL

    H. ADAMSKA-DYNIEWSKA, W. TKACZEWSKI, ... S. DZIEKANSKI

    Pages 183-186

  33. Book chapterNo access

    ELECTROPHYSIOLOGICAL BASES OF ANTIFIBRILLATORY ACTION OF CHINOIN-103

    J. MÉSZÁROS, J. SZEGI, ... G. KOVACS

    Pages 187-190

  34. Book chapterNo access

    MICROELECTROPHYSIOLOGICAL PROCEDURE FOR THE ANALYSIS OF DRUG EFFECTS ON THE ATRIOVENTRICULAR CONDUCTING SYSTEM

    M. NÉMETH, J.GY. PAPP and L. SZEKERES

    Pages 191-195

  35. Book chapterNo access

    SERUM LEVELS OF DIGOXIN DURING COMBINED TREATMENT WITH DIGOXIN AND AMIODARONE

    H. ADAMSKA-DYNIEWSKA, W. TKACZEWSKI and R. BRZOZOWSKI

    Pages 197-199

  36. Book chapterNo access

    THE INOTROPIC EFFECT OF ISOPROTERENOL AND DOPAMINE UNDER DIFFERENT LEVELS OF OXYGENATION

    V.V. TKACHUK

    Pages 201-204

  37. Book chapterNo access

    THE INFLUENCE OF DOXORUBICIN COMBINED WITH OTHER DRUGS ON HAEMODYNAMIC PARAMETERS IN RABBITS

    J. DRZEWOSKI

    Pages 205-209

  38. Book chapterNo access

    NEW ANTIARRHYTHMIC AGENT WITH POSITIVE CARDIAC ACTIONS (GYKI-38 233)

    M. KÜRTHY, G. RABLOCZKY, ... I. ÉRCZY

    Pages 211-215

  39. Book chapterNo access

    CARDIAC ELECTROPHYSIOLOGICAL EFFECTS OF LYSOLECITHIN, AN ISCHAEMIC METABOLITE, ON RABBIT ATRIAL AND VENTRICULAR MYOCARDIUM

    T. FAZEKAS, M. NÉMETH, ... L. SZEKERES

    Pages 217-222

  40. Book chapterNo access

    ACUTE AND CHRONIC EFFECTS OF IPRATROPIUM BROMIDE (ITROP) IN PATIENTS WITH BRADYCARDIA

    M. BÉKÉS and K. ZÁMOLYI

    Pages 223-226

  41. Book chapterNo access

    MYOCARDIAL PROTECTION BY COMPUTERISED LONG-TIME CONTROLLING OF THE MYOCARDIAL GLUCOSE-, INSULIN-, FATTY ACID-SUPPLY IN MAN

    R. MÖRICKE, M. KIESEWETTER, ... V. DETSCHEV

    Pages 227-231

  42. Book chapterNo access

    CHEMICAL AND BIOCHEMICAL PARAMETERS ASSOCIATED WITH NEW CARDIOVASCULAR DRUGS

    G. DE STEVENS

    Pages 245-249

  43. Book chapterNo access

    LIST OF CONTRIBUTORS

    Pages 233-236

  44. Book chapterNo access

    SUBJECT INDEX

    Pages 237-242

  45. Book chapterNo access

    LIST OF CONTRIBUTORS

    Pages 409-414

  46. Book chapterNo access

    SUBJECT INDEX

    Pages 415-417

About the book

Description

Advances in Pharmacological Research and Practice, Volume 1: Pharmacological Protection of the Myocardium presents the proceedings of the 4th Congress of the Hungarian Pharmacological Society, held in Budapest, Hungary in 1985. This book presents a comprehensive view of the development in the fields of pharmacological protection of the myocardium and the pharmacology of the vascular system. Organized into two sections encompassing 70 chapters, this volume begins with an overview of the ischemic biochemical changes with emphasis on the role of cAMP and the protein kinase system. This text then explores the cellular electrophysiological disorders seen in acute myocardial ischemia as well as their pharmacological modification. Other chapters consider the prevention of primary ventricular fibrillation that includes measures aimed at maintaining electrical stability. The final chapter deals with drugs affecting beneficially the pathological lipoprotein levels. This book is a valuable resource for cardiologists and pharmacologists.

Advances in Pharmacological Research and Practice, Volume 1: Pharmacological Protection of the Myocardium presents the proceedings of the 4th Congress of the Hungarian Pharmacological Society, held in Budapest, Hungary in 1985. This book presents a comprehensive view of the development in the fields of pharmacological protection of the myocardium and the pharmacology of the vascular system. Organized into two sections encompassing 70 chapters, this volume begins with an overview of the ischemic biochemical changes with emphasis on the role of cAMP and the protein kinase system. This text then explores the cellular electrophysiological disorders seen in acute myocardial ischemia as well as their pharmacological modification. Other chapters consider the prevention of primary ventricular fibrillation that includes measures aimed at maintaining electrical stability. The final chapter deals with drugs affecting beneficially the pathological lipoprotein levels. This book is a valuable resource for cardiologists and pharmacologists.

Details

ISBN

978-0-08-034190-3

Language

English

Published

1986

Copyright

Copyright © 1986 Elsevier Ltd. All rights reserved.

Imprint

Pergamon

You currently don’t have access to this book, however you can purchase separate chapters directly from the table of contents or buy the full version.

Purchase the book

Editors

L. SZEKERES

Department of Pharmacology, University Medical School, Szeged, Hungary

J.GY. PAPP

Department of Pharmacology, University Medical School, Szeged, Hungary

L. TARDOS

Institute for Drug Research, Budapest, Hungary

G. RABLOCZKY

Institute for Drug Research, Budapest, Hungary